Legal & General Group’s American Renal Associates Holdings, Inc ARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,377
| Closed | -$16K | – | 3542 |
|
|
2020
Q4 | $16K | Hold |
1,377
| – | – | ﹤0.01% | 3190 |
|
|
2020
Q3 | $10K | Sell |
1,377
-602
| -30% | -$3.95K | ﹤0.01% | 3248 |
|
|
2020
Q2 | $13K | Sell |
1,979
-770
| -28% | -$4.97K | ﹤0.01% | 3253 |
|
|
2020
Q1 | $18K | Sell |
2,749
-686
| -20% | -$5.98K | ﹤0.01% | 2955 |
|
|
2019
Q4 | $36K | Buy |
3,435
+334
| +11% | +$2.86K | ﹤0.01% | 2969 |
|
|
2019
Q3 | $20K | Hold |
3,101
| – | – | ﹤0.01% | 3141 |
|
|
2019
Q2 | $22K | Buy |
3,101
+1,146
| +59% | +$7.56K | ﹤0.01% | 3170 |
|
|
2019
Q1 | $12K | Hold |
1,955
| – | – | ﹤0.01% | 3228 |
|
|
2018
Q4 | $23K | Hold |
1,955
| – | – | ﹤0.01% | 3035 |
|
|
2018
Q3 | $42K | Hold |
1,955
| – | – | ﹤0.01% | 2870 |
|
|
2018
Q2 | $31K | Buy |
1,955
+88
| +5% | +$1.38K | ﹤0.01% | 3015 |
|
|
2018
Q1 | $35K | Sell |
1,867
-198
| -10% | -$3.91K | ﹤0.01% | 2924 |
|
|
2017
Q4 | $36K | Sell |
2,065
-785
| -28% | -$10.8K | ﹤0.01% | 2980 |
|
|
2017
Q3 | $43K | Hold |
2,850
| – | – | ﹤0.01% | 2960 |
|
|
2017
Q2 | $53K | Hold |
2,850
| – | – | ﹤0.01% | 2910 |
|
|
2017
Q1 | $48K | Hold |
2,850
| – | – | ﹤0.01% | 2882 |
|
|
2016
Q4 | $60K | Buy |
2,850
+1,464
| +106% | +$30K | ﹤0.01% | 2832 |
|
|
2016
Q3 | $25K | Hold |
1,386
| – | – | ﹤0.01% | 2782 |
|
|
2016
Q2 | $40K | Buy |
+1,386
| New | +$38.6K | ﹤0.01% | 2585 |
|
Legal & General Group's ARA Position: Q1 2021 in Review
Legal & General Group sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 1,377 shares — an estimated $16K sold.
Legal & General Group first reported a position in ARA in Q2 2016 and held it in 19 quarters. The position peaked at $60K in Q4 2016. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.
- Legal & General Group reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
- Legal & General Group sold 1,377 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $16K.
- Legal & General Group first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 19 quarters.
- Legal & General Group's American Renal Associates Holdings, Inc position peaked at $60K in Q4 2016.
- 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.
Based on Legal & General Group's 13F filing for Q1 2021, filed 17 May 2021.